Hutchison China MediTech (Chi-Med), Eli Lilly and Company (JOBS) Expand Drug Deal
Nov 21 (Reuters) - Hutchison China Meditech Ltd, a traditional Chinese medicine-sourced pharmaceuticals maker, said on Friday it has expanded its drug discovery and development partnership with Eli Lilly and Co (LLY.N: Quote, Profile, Research, Stock Buzz) focused on an additional target in oncology.